Parkinson's Disease News and Research

RSS
Parkinson's disease is a brain disorder. It occurs when certain nerve cells (neurons) in a part of the brain called the substantia nigra die or become impaired. When approximately 80 percent of neurons are damaged, the symptoms of Parkinson's disease appear. Parkinson's disease affects 1 in 100 people over the age of 60, with the average age of onset being 60 years. The risk of developing Parkinson's disease increases with age. In the United States, it is estimated that 60,000 new cases of Parkinson's disease are diagnosed each year, with 1.5 million Americans currently living with the disease.
Editor's Pick: Life Science Interviews from 2019

Editor's Pick: Life Science Interviews from 2019

Study provides new insights into small acidic protein linked to Parkinson's disease

Study provides new insights into small acidic protein linked to Parkinson's disease

Researchers use new eye movement test to study brain aging effects

Researchers use new eye movement test to study brain aging effects

Essential tremor caused by overactive brain waves

Essential tremor caused by overactive brain waves

UMN and Windgap Medical collaborate to design cyanide antidote autoinjector

UMN and Windgap Medical collaborate to design cyanide antidote autoinjector

Boosting the number of neurons improves learning and memory of old mice

Boosting the number of neurons improves learning and memory of old mice

First patient recruited for UK-wide Parkinson's disease trial

First patient recruited for UK-wide Parkinson's disease trial

Missing one night of sleep may increase Alzheimer's biomarker, study finds

Missing one night of sleep may increase Alzheimer's biomarker, study finds

Dresden scientists identify newborn neurons in zebrafish

Dresden scientists identify newborn neurons in zebrafish

Studying Alzheimer’s and Parkinson’s Disease using Pre-Formed Fibrils

Studying Alzheimer’s and Parkinson’s Disease using Pre-Formed Fibrils

A new kind of testing for patients with Parkinson's disease

A new kind of testing for patients with Parkinson's disease

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

GB Sciences announces preclinical results of promising formulations for Parkinson's disease

Medicinal cannabis substitute may help unlock new treatment for Parkinson's disease

Medicinal cannabis substitute may help unlock new treatment for Parkinson's disease

Obesity, but not poor diet and lack of exercise, associated with higher dementia risk

Obesity, but not poor diet and lack of exercise, associated with higher dementia risk

Weekly exercise regimen improves motor and non-motor symptoms in Parkinson's patients

Weekly exercise regimen improves motor and non-motor symptoms in Parkinson's patients

Cancer drug shows promise in battling Parkinson’s disease

Cancer drug shows promise in battling Parkinson’s disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

Study shows nilotinib drug is safe and well tolerated in patients with Parkinson's disease

New gene therapy has potential to reverse disease processes

New gene therapy has potential to reverse disease processes

New study improves understanding of widespread diseases

New study improves understanding of widespread diseases

Neuroscientists develop new method for uniquely targeted gene therapy

Neuroscientists develop new method for uniquely targeted gene therapy